The H-ARS Dose Response Relationship (DRR): Validation and Variables

dc.contributor.authorPlett, P. Artur
dc.contributor.authorSampson, Carol H.
dc.contributor.authorChua, Hui Lin
dc.contributor.authorJackson, William
dc.contributor.authorVemula, Sasidhar
dc.contributor.authorSellamuthu, Rajendran
dc.contributor.authorFisher, Alexa
dc.contributor.authorFeng, Hailin
dc.contributor.authorWu, Tong
dc.contributor.authorMacVittie, Thomas J.
dc.contributor.authorOrschell, Christie M.
dc.contributor.departmentDepartment of Medicine, School of Medicineen_US
dc.date.accessioned2017-09-22T20:24:45Z
dc.date.available2017-09-22T20:24:45Z
dc.date.issued2015-11
dc.description.abstractManipulations of lethally-irradiated animals, such as for administration of pharmaceuticals, blood sampling, or other laboratory procedures, have the potential to induce stress effects that may negatively affect morbidity and mortality. To investigate this in a murine model of the hematopoietic acute radiation syndrome, 20 individual survival efficacy studies were grouped based on the severity of the administration (Admn) schedules of their medical countermeasure (MCM) into Admn 1 (no injections), Admn 2 (1-3 injections), or Admn 3 (29 injections or 6-9 oral gavages). Radiation doses ranged from LD30/30 to LD95/30. Thirty-day survival of vehicle controls in each group was used to construct radiation dose lethality response relationship (DRR) probit plots, which were compared statistically to the original DRR from which all LDXX/30 for the studies were obtained. The slope of the Admn 3 probit was found to be significantly steeper (5.190) than that of the original DRR (2.842) or Admn 2 (2.009), which were not significantly different. The LD50/30 for Admn 3 (8.43 Gy) was less than that of the original DRR (8.53 Gy, p < 0.050), whereas the LD50/30 of other groups were similar. Kaplan-Meier survival curves showed significantly worse survival of Admn 3 mice compared to the three other groups (p = 0.007). Taken together, these results show that stressful administration schedules of MCM can negatively impact survival and that dosing regimens should be considered when constructing DRR to use in survival studies.en_US
dc.eprint.versionAuthor's manuscripten_US
dc.identifier.citationPlett, P. A., Sampson, C. H., Chua, H. L., Jackson, W., Vemula, S., Sellamuthu, R., … Orschell, C. M. (2015). The H-ARS Dose Response Relationship (DRR): Validation and Variables. Health Physics, 109(5), 391–398. http://doi.org/10.1097/HP.0000000000000354en_US
dc.identifier.issn1538-5159en_US
dc.identifier.urihttps://hdl.handle.net/1805/14175
dc.language.isoen_USen_US
dc.publisherOvid Technologies (Wolters Kluwer) - Lippincott Williams & Wilkinsen_US
dc.relation.isversionof10.1097/HP.0000000000000354en_US
dc.relation.journalHealth Physicsen_US
dc.rightsPublisher Policyen_US
dc.sourcePMCen_US
dc.subjectAcute Radiation Syndromeen_US
dc.subjectetiologyen_US
dc.subjectphysiopathologyen_US
dc.subjectDisease Models, Animalen_US
dc.subjectDose-Response Relationship, Radiationen_US
dc.subjectRadiation-Protective Agentsen_US
dc.subjectadministration & dosageen_US
dc.subjectWhole-Body Irradiationen_US
dc.subjectadverse effectsen_US
dc.titleThe H-ARS Dose Response Relationship (DRR): Validation and Variablesen_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
nihms707180.pdf
Size:
245.69 KB
Format:
Adobe Portable Document Format